Tempest Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Tempest Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TPST | Tempest Therapeutics | -$5.33 | -$3.27 | — | — | $0.00 | — | — | — | 11/11/2025 | |
TPST | Tempest Therapeutics | -$5.52 | -$2.88 | -$2.07 | 28.12% | $0.00 | — | $0.00 | — | 08/11/2025 | |
TPST | Tempest Therapeutics | -$4.62 | -$4.03 | -$3.16 | 21.59% | $0.00 | — | $0.00 | — | 05/13/2025 | |
TPST | Tempest Therapeutics | -$4.42 | -$3.25 | -$5.07 | -56.00% | $0.00 | — | $0.00 | — | 03/27/2025 | |
TPST | Tempest Therapeutics | -$6.24 | -$4.55 | -$5.33 | -17.14% | $0.00 | — | $0.00 | — | 11/12/2024 | |
TPST | Tempest Therapeutics | -$7.02 | -$5.20 | -$5.46 | -5.00% | $0.00 | — | $0.00 | — | 08/08/2024 | |
TPST | Tempest Therapeutics | -$7.15 | -$5.07 | -$4.68 | 7.69% | $0.00 | — | $0.00 | — | 05/09/2024 | |
TPST | Tempest Therapeutics | -$8.19 | -$5.07 | -$4.42 | 12.82% | $0.00 | — | $0.00 | — | 03/19/2024 | |
TPST | Tempest Therapeutics | -$8.58 | -$7.41 | -$6.24 | 15.79% | $0.00 | — | $0.00 | — | 11/08/2023 | |
TPST | Tempest Therapeutics | -$10.27 | -$6.76 | -$7.02 | -3.85% | $0.00 | — | $0.00 | — | 08/10/2023 | |
TPST | Tempest Therapeutics | -$15.34 | -$8.32 | -$7.15 | 14.06% | $0.00 | — | $0.00 | — | 05/10/2023 | |
TPST | Tempest Therapeutics | $0.26 | -$9.88 | -$8.19 | 17.11% | $0.00 | — | $0.00 | — | 03/22/2023 | |
TPST | Tempest Therapeutics | -$15.73 | -$10.40 | -$8.58 | 17.50% | $0.00 | — | $0.00 | — | 11/08/2022 | |
TPST | Tempest Therapeutics | -$99.19 | — | -$10.27 | — | $0.00 | — | $0.00 | — | 08/15/2022 | |
TPST | Tempest Therapeutics | -$137.15 | — | -$15.34 | — | $0.00 | — | $0.00 | — | 05/13/2022 | |
TPST | Tempest Therapeutics | — | -$15.99 | $0.26 | 101.63% | — | — | $0.00 | — | 03/29/2022 | |
TPST | Tempest Therapeutics | -$145.86 | -$13.65 | -$15.73 | -15.24% | — | — | $0.00 | — | 11/10/2021 | |
TPST | Tempest Therapeutics | -$148.46 | -$12.22 | -$99.19 | -711.70% | — | — | $0.00 | — | 08/12/2021 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-11 | $-2.07 | $-2.88 | 28.1 % |
Q1 | 2025-05-13 | $-3.16 | $-4.03 | 21.6 % |
Q4 | 2025-03-27 | $-5.07 | $-3.25 | -56.0 % |
Q3 | 2024-11-12 | $-5.33 | $-4.55 | -17.1 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Está previsto que Tempest Therapeutics (TPST) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 11, 2025 para el Q2.
El BPA real fue de $-2.07, que superó la estimación de $-2.88.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.